August 04, 2026 (MLN): Tasdeeq Information Services Limited, Pakistan's first SBP-licensed credit bureau, is about to become the first company of its kind to list on the Pakistan Stock Exchange. For an ordinary investor, that novelty is exactly the problem: there is no other listed credit bureau in Pakistan to compare it against, no long trading history to study, and only one profitable year on the company's books.

This piece is an attempt to give investors everything they need to make an informed call, what the business does well, where the prospectus itself flags risk, the questions we put directly to CEO Mumtaz Hussain on investors' behalf, his responses in full, and Mettis Global's own observations on the valuation methodology.

Nothing here is a recommendation to subscribe or avoid the issue, it is the fullest picture we can put together so you can decide for yourself.

1. The Company, in Brief

2. What Works in This Company's Favour

●      A real regulatory moat: SBP licensing under the Credit Bureaus Act, 2015 is a two-stage gate, a license followed by a mandatory operational audit before the bureau can go live.

●      Demand that is not discretionary: banks and NBFCs are required by prudential regulation to pull a credit report before lending, so the core B2B revenue line moves with the size of formal lending in the country, not with sales effort.

●      A genuine earnings inflection, not just a one-off: revenue CAGR of 38% (CY2023–CY2025), operating margin swung from -29.7% to +19.1%, and, per management's response below, margins have widened further to 29% in the five months to May 2026.

●      A data moat: roughly 41.5 million borrower records built over about 11 years, covering 174 member institutions, not something a new entrant can replicate quickly.

●      A real, capital-at-risk signal from informed insiders: Pre-IPO Placement investors bought in at PKR 2.35, a 23.68% premium to the Floor Price, with a lock-in period.

●      A clean issuer litigation record: no case pending against the Company itself beyond a routine, low-value FBR withholding-tax matter, and no overdue loans anywhere in the group.

Reading the prospectus alone only gets an investor so far, a document written by the company, for the purpose of raising money from the company, will naturally present its best case.

So we went further. We built a list of the questions that mattered most from a fair reading of the risk factors, the valuation section and the financial statements, and put them directly to CEO Mumtaz Hussain, on the record, for this piece.

The idea was simple: don't just repeat what the prospectus says, test it. Where the answers held up, we've said so. Where they didn't fully resolve a concern, we've flagged that too. The full exchange, questions and answers, unedited, follows below.

3. Our Questions to Management and Their Answers, In Full

We put the following questions directly to Tasdeeq's CEO, Mumtaz Hussain, ahead of publication. His team's responses are reproduced below exactly as received, unedited, so investors can weigh the company's own explanation alongside the concerns raised in the prospectus.

On the track record and valuation

Q: CY2025 is Tasdeeq's only profitable year on record, after losses in CY2023 and CY2024. What specifically gives confidence this is a sustained inflection rather than a one-year swing, and is there anything from Q1–Q2 CY2026 that confirms the trend is holding?

A: The inflection is operating leverage, not a one-year revenue swing. On a like-for-like basis, revenue grew from PKR 167 million in CY2023 to PKR 318 million in CY2025, up 90%, while total operating expenses rose 24%, from PKR 208 million to PKR 258 million. In CY2025 alone revenue grew 72% against operating expense growth of 8%. That relationship is a property of the cost base — technology platform, data center and salaries are substantially fixed — so it repeats as volumes grow. 

On CY2026, the prospectus carries management accounts for the five months to 31 May 2026: revenue of PKR 180 million and operating margin of 29%, against 19% for CY2025. Margins have continued to widen.

Q: The DCF fair value of PKR 3.82/share assumes a Beta of 1.0, which the prospectus itself describes as "assumed" since there are no direct comparables. How was that number arrived at, and how sensitive is the PKR 3.82 figure to a Beta of, say, 1.2 or 1.5?

A: There is no company in Tasdeeq's line of business listed on the Pakistan Stock Exchange, so there is no observable beta to derive. A beta of 1.0 was adopted as the neutral assumption. On sensitivity, holding the projected cash flows constant and varying only beta: at 1.2 the value is PKR 3.46 per share, and at 1.5 it is PKR 3.01 per share. The Floor Price of PKR 1.90 remains at a 45% and 37% discount respectively.

Q: Nearly three-quarters of the DCF equity value comes from Terminal Value beyond 2030, not the explicit five-year forecast. Doesn't that make the "50% discount to intrinsic value" pitch to retail investors overstate the certainty of that number? The domestic peer comparison used for relative valuation is PACRA, which is also a sponsor and shareholder of Tasdeeq. Why is a related party the benchmark used to argue the IPO is underpriced, and was an independent comparable considered instead?

A: The terminal value is PKR 2,641 million of a PKR 3,630 million equity value — but a terminal value of this weight is normal in DCF and not specific to this transaction. In a five-year DCF the explicit period captures only a fraction of the asset's life; the balance necessarily sits in the terminal value. It is standard for terminal value to represent 60% to 80% of equity value, and higher where cash flows are still scaling in the final forecast year.  The relationship is disclosed in the comparison table mentioned in the prospectus, which states that PACRA is a Sponsor of the Company.

The prospectus also states that PACRA is not a direct or exact comparable, does not operate a licensed credit bureau, and that no company in Tasdeeq's line of business is listed on the Pakistan Stock Exchange.  The figure taken from PACRA is a market-observed trading multiple, set by the market rather than supplied by the company. PACRA's shareholding in Tasdeeq does not influence the price at which its own shares trade. It was selected because it is the closest listed structural analogue in Pakistan — one of only two SECP-licensed credit rating agencies, licensed, high barrier to entry.

There is no independent listed Pakistani credit bureau to use instead.  It is also one of three legs. The global comparison uses Experian, Equifax and TransUnion at an average of 24.02x, which is unrelated and closer on business model.

Separately, minority shareholders placed 69,000,000 shares at PKR 2.35, a 23.68% premium to the Floor Price with a one-month lock-in — an arms-length third-party mark. The DCF and the global comparison support the Floor Price independently of PACRA.

Q: The five-year projections assume operating margin nearly triples, from 24% in CY2026 to 54% by CY2030, including a 100% YoY growth assumption for the Digital Banks lending segment for three consecutive years. What's the basis for that specific assumption, given it's currently a near-zero base?

A: The prospectus footnotes that the Digital Banks growth rate is high because of the low base effect. The segment contributes nothing in CY2026 and roughly PKR 28 million by CY2030, around 1.3% of projected revenue. Removing it entirely would not materially change the valuation. The regulatory basis is nonetheless real: each digital bank commencing operations must join a credit bureau and obtain a credit information report before lending. 

On margins, the expansion follows from the cost assumptions, not an assumed efficiency gain. Salaries grow at approximately 15% per annum and general and administrative costs at approximately 10%, against revenue growth of 33% to 70%. Because the platform, data centre and core salary base are step-fixed, incremental revenue is earned at a proportionately lower incremental cost.  The strongest support is that this has already happened once on audited numbers.

In CY2025, revenue grew 72.3% while total operating expenses grew 7.6%, moving operating margin from negative 29.7% to positive 19.1% in a single year. The projected path applies the same mechanism to a larger base.

On use of proceeds

Q: As of June 30, 2026, no vendors are finalized and no formal quotations obtained for any part of the PKR 285 million raise. When are vendor contracts expected to be locked in, and how much execution risk does that create for the 18–21 month deployment timeline?

A: We appreciate why this stands out, and it was a considered choice — one we disclosed ourselves in the risk factors. We did engage multiple vendors while preparing our estimates; the practical challenge is that in Pakistan's import environment, hardware quotations remain valid for only a matter of days, given exchange-rate movements and import lead times.

A quotation locked months before funds are available would no longer reflect real prices, so we felt the more honest course was to present management estimates at prevailing market rates. What is already settled is substantial: the full equipment list with several authorized distributors in Pakistan and a quarter-by-quarter schedule, with the first tranche planned for 3Q26, the listing quarter itself. Deployment will be disclosed quarterly.

Q: A material share of that spend is USD-denominated at an assumed PKR 280/USD. What's the contingency if the rupee depreciates materially before procurement, does marketing or infrastructure spend get cut, or does the company absorb the difference?

A: It's an important question, part of the spend is USD-linked — imported hardware, and advertising platforms that bill in dollars — which is why we disclosed PKR 280 as the planning rate and flagged currency risk plainly in the prospectus. The use of proceeds was designed with that volatility in mind: deployment is phased over 18–21 months, so purchases are staged across the cycle rather than converted at any single day's rate; each stage is competitively tendered at prevailing prices; and digital marketing is bought in short cycles that adjust naturally in timing and mix.

The Company is now profitable and cash-generative in its own right. Beyond that, we'd rather not single out any one part of the use of proceeds in a hypothetical today. If a material movement were ever to require a trade-off, the Board would weigh it carefully and take the course that best serves the Company and all its shareholders — with the decision fully visible through the quarterly, utilization reports.

On governance and legal exposure

Q: The board is still awaiting SBP approval for an additional independent director and a female director. Why wasn't this completed before listing, and what's the expected timeline?

A: Tasdeeq initiated the appointment process well in advance of the listing and submitted the proposed appointments to the State Bank of Pakistan (SBP) for the required Fit and Proper Test (FPT) approval. We are pleased to confirm that the FPT approvals for both the additional independent director and the female director have been received before the listing.

Q: Sir, along with two other Tasdeeq directors, is personally named in the ongoing PACRA ownership litigation as part of the "Buyers Group." Even though Tasdeeq isn't a party to the case, how is that personal legal exposure separated from fiduciary duty to Tasdeeq shareholders, and when is resolution expected?

A: The proceedings referred to are personal to the individuals concerned and have been disclosed in the Prospectus in accordance with the applicable legal and regulatory requirements. Tasdeeq is not a party to the litigation, and the matters do not relate to the Company's business, operations, assets, or financial position. 

As the proceedings are currently sub judice, it would not be appropriate for the Company or the individuals concerned to comment on their merits or likely outcome. The directors remain subject to their fiduciary and statutory duties under applicable law and are required to act at all times in the best interests of Tasdeeq and all of its shareholders. There is no impact on the Company's governance or day-to-day operations arising from these proceedings.

Q: The SECP show-cause notice against PACRA and its directors specifically concerns PACRA's disclosures around its investment in Tasdeeq. Could you walk us through what that notice alleges, in plain terms, for our readers?

A: The matter has been disclosed in the Prospectus in accordance with the applicable legal and regulatory requirements. As the matter is currently under consideration by the regulator, it would not be appropriate for the Company to comment on the merits or the likely outcome beyond the disclosures already made in the Prospectus.

On the business itself

Q: The top 10 customers make up 62% of CY2025 revenue, and 89% of revenue overall comes from the B2B segment. What happens to the numbers if even two of those large customers shift volume to DataCheck or eCIB?

A: Customer concentration is a characteristic of any industry operating in a Oligopoly. In a competitive market, customers may periodically reallocate part of their enquiry volumes between credit bureaus based on commercial terms, service quality, technology, or operational requirements. Our financial projections have been prepared on a prudent basis and assume Tasdeeq at approximately 50% market share.

As a result, the projections already incorporate the likelihood of normal fluctuations in customer volumes and competitive dynamics.  In addition, Tasdeeq's strategy is focused on reducing customer concentration over time by broadening its revenue base. We are expanding beyond the traditional B2B segment into the significantly larger B2C market, including services for tenant screening, employment verification, informal lending, consumer leasing, and other credit assessment use cases.

This represents a substantial addressable market—estimated to exceed PKR 50 billion—and is expected to diversify our customer base and revenue streams over the medium to long term.  Accordingly, while changes in enquiry volumes from individual large customers may affect revenue in a particular period, management does not expect such movements to have a material impact on the long-term growth prospects of the business.

Q: The current ratio has stayed below 1.0x in every year shown, including the profitable CY2025. What's the reason, and is there a plan to strengthen working capital once the company is listed and answerable to public shareholders?

A: The current ratio reflects management's deliberate decision to reinvest internally generated cash flows into the development of Tasdeeq's B2C platform and mobile application rather than maximizing short-term liquidity.

These investments were intended to support the Company's long-term growth strategy and expand its addressable market beyond the traditional B2B credit bureau business.  Following the listing, the Company shall have dedicated funding to accelerate the development and commercialization of the B2C platform.

This will reduce the need to finance these investments from working capital generated by the core business, thereby strengthening liquidity and improving the current ratio over time.

On the Pre-IPO Placement

Q: Pre-IPO Placement investors (United Bank Limited, Growth Securities, and two individual investors) are buying 69 million shares at PKR 2.35 — a 23.68% premium to the floor price — with transfer completed within five working days of General Public Subscription. The prospectus states these Pre-IPO shares cannot be sold, transferred, or disposed of for 30 days from the date of Listing. Given that this is a comparatively short lock-in versus sponsor lock-ins on other share blocks, what protects general public subscribers from a coordinated sell-off by Pre-IPO investors as soon as that 30-day window closes?

A: The Pre-IPO investors are well-established institutional and strategic investors whose investment decisions are expected to be based on the Company's long-term value creation. The interests of all shareholders remain aligned with the Company's objective of delivering sustainable growth and enhancing shareholder value over the long term.  Following the expiry of the lock-in period applicable to the Pre-IPO investors, any sale of shares will take place through the Pakistan Stock Exchange in accordance with applicable securities laws, listing regulations, and normal market mechanisms. The Company does not seek to influence the investment decisions of any shareholder, as those decisions are entirely at the discretion of the respective investors. 

That said, we believe the Pre-IPO investors' decision to invest at a 23.68% premium to the IPO floor price reflects their confidence in Tasdeeq's long-term growth prospects. We therefore hope that they, along with all other shareholders, will focus on the long-term value creation potential of the Company rather than short-term trading gains.

4. Observation on the Valuation

Beyond management's answers, our own reading of the valuation section raises a few methodology questions we think investors should have answered before subscribing. These aren't allegations of wrongdoing, they are the kind of fine-print items a careful investor, or their broker, should be able to walk through line by line.

●      Multiple calculated on face value, not net book value: the valuation multiples in the prospectus appear to be worked out using the face value of the share (PKR 1) rather than net book/asset value per share. That gap can effectively function as a built-in premium that isn't separately called out, on a rough illustration, reworking the multiple on a net-value basis could push the implied price meaningfully higher (in the region of another 90 paisa per share) than the face-value-based calculation in the prospectus.

●      The company looks under-leveraged for this raise: with debt-to-equity as low as 0.03x in CY2025, at least part of this funding requirement could reasonably have been met through debt rather than an all-equity raise, equity being the more expensive form of capital and the one that dilutes existing and incoming shareholders the most.

●      The peer comparison itself is questionable, not just the sponsor-relationship issue: PACRA and the global peers (Experian, Equifax, TransUnion) run different business models to Tasdeeq's, so treating them as comparables is debatable on its own terms. If a peer-based approach is used at all, the average Beta of the peer set should arguably be used in the DCF, rather than an assumed Beta of 1.0.

●      Marketing spend funded from IPO proceeds: marketing is normally an operating cost, and would ordinarily be funded from operational cash flows rather than from equity raised in an IPO, particularly for a company that is now describing itself as profitable and cash-generative.

●      Revenue assumptions are not broken down: the prospectus does not provide detailed, product- or segment-wise assumptions behind the revenue drivers underlying the five-year projections, which makes it difficult for an outside investor to independently stress-test the growth numbers.

●      The current ratio is sub-1x on the audited accounts specifically: on the audited historical numbers (not just the CY2026 management accounts), current liabilities have exceeded current assets in every year shown, a working-capital position worth flagging on its own, separate from management's explanation above.

●      Admin expenses look static despite revenue growth in the management accounts: on the audited financials, administrative expenses did not move materially even as revenue rose in the CY2026 management accounts period, and the prospectus does not explain the divergence.

●      Shareholding structure needs more granularity: a fully detailed shareholding structure of both major shareholder groups would help investors assess whether there is any indirect holding link back to PACRA or its related directors, relevant given the live SECP matter concerning PACRA's own disclosures about its investment in Tasdeeq.

 The Bottom Line

Strip away the noise and this is a company with a real, regulation-protected moat, a genuine and recently-audited earnings turnaround, and management that, to its credit, answered every question we put to it directly and in detail, including on points the prospectus itself flags as risks. That counts for something in a market where companies often go quiet under scrutiny.

At the same time, investors should go in with eyes open on where the story is still being written rather than proven: one profitable year is being used to underwrite a five-year projection with materially higher margins; a large share of the valuation sits in a terminal value built on an admittedly assumed Beta; the domestic peer used for comparison is a related party, even if management makes a reasoned case for using it; working capital has run tight throughout the company's audited history; and vendor contracts for the IPO proceeds are not yet locked in.

 None of these, individually, is disqualifying, but together they are exactly the kind of fine print an investor should read before anchoring on the headline "undervalued" pitch.

As always, this is not investment advice. Investors should read the full Prospectus and the Supplement once the Strike Price is announced, and consider their own risk appetite before deciding whether to subscribe.

Copyright Mettis Link News